Navigation Links
InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet™ (Pirfenidone) in Europe
Date:12/17/2010

n the European headquarters in Basel, Switzerland and has worked in Switzerland, the UK, the US and Italy.  The following executives will report to Mr. Di Nepi.
  • Senior Vice President, EU Medical and Global Medical Advisor – Frank T. Weber, M.D.   Dr. Weber has 20 years of industry experience, having served most recently as Chief Medical Officer at Merck Serono where he played a key role in the registration and reimbursement processes in Europe for Erbitux® (cetuximab).  Dr. Weber previously served in various medical affairs positions at American Cyanamid/Lederle, Sythelabo and Merck KGaA.  He also worked on the national reimbursement side as Medical Director with MedNet, a Munich Re/United Health Care joint venture.  Dr. Weber began his career in healthcare as a surgeon and immunologist.  Dr. Weber has worked in Germany, Switzerland, France, the UK and the United States.  He will be based in the European headquarters in Basel, Switzerland.
  • Senior Vice President and General Manager, Germany – Markus Leyck Dieken, M.D. Dr. Dieken joins InterMune from Novartis, where he was Head of the European Region for the vaccines business and Managing Director of Novartis-Behring's German operations.  Prior to Novartis, he served for 10 years with Novo Nordisk Germany in various roles in Medical Affairs, Marketing and Sales, and then as General Manager of the German subsidiary and Vice President, Central Europe.  He has worked in Germany and Switzerland.  Dr. Leyck Dieken will be based in Berlin, Germany.  
  • Vice President, Sales and Marketing, Europe – Ms. Manuela Maronati.  Ms. Maronati brings 15 years of sales and marketing experience, including the past seven years with Amgen where she served as an International Senior Marketing Manager on the Neupogen® (filgrastim) franchise, and where she previously launched a new medical device f
    '/>"/>

  • SOURCE InterMune, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. InterMune to Release Third Quarter Financial Results on October 28
    2. InterMune Sells Danoprevir Rights to Roche for $175 Million
    3. InterMune to Present at 2010 Citi Health Care Conference
    4. InterMune Receives FDA Complete Response Letter on Esbriet(TM) (Pirfenidone) New Drug Application
    5. InterMune to Release First Quarter Financial Results on April 29
    6. InterMune Announces Submission of MAA for Pirfenidone for the Treatment of Patients With IPF
    7. InterMune Announces Proposed Public Offering of Common Stock
    8. InterMune to Release Third Quarter Financial Results on November 5
    9. InterMune Announces Collaboration With National Jewish Health on NIH-Supported Genetic Research in Idiopathic Pulmonary Fibrosis
    10. InterMune to Present at Canaccord Adams Conference
    11. InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... , December 23, 2014 ... Algeria , out today and available for free download ... actors driving change and growth in the sector today. ... scored notable successes has been in developing a homegrown pharmaceutical ... percent local production still remains some way off. A cursory ...
    (Date:12/24/2014)... Dec. 23, 2014  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... filed a Clinical Trial Application (CTA) with the ... Agency (MHRA) seeking regulatory approval to initiate clinical trials ... Citrate. Contingent on the Company receiving CTA ... I trial to assess the safety, tolerability and dose ...
    (Date:12/22/2014)... Brussels (PRWEB) December 22, 2014 The ... the global leader of technical training across the life ... Clinical Data Management (SCDM) to provide the organization's ... certification programs —providing access to the more than 350 ... SCDM members with 10% off when registering for a ...
    (Date:12/22/2014)... - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), ... development of autologous cell therapies, announced today the publication ... in conjunction with co-authors from Kyoto University and the ... ongoing clinical research using dermal sheath cup (DSC) cells ... The paper entitled " Hair Follicle Dermal Stem Cells ...
    Breaking Biology Technology:PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5
    ...  Verenium Corporation (Nasdaq: VRNM ), a leading ... of high-performance enzymes, today announced that James Levine, Executive ... the upcoming Baird 2011 Clean Technology Conference.  The presentation ... Thursday, December 1, 2011 and will take place at ...
    ... Inc. (OTCBB: MDRM) (the "Company") is pleased to announce ... its closing agreement to acquire all of the common ... Mobility Aids, Inc. is a Nevada-based Company whose strategic ... Bio-Pharma sector as well as scalable manufacturing in niche ...
    ... Santa Barbara, Calif. Professor Kaustav Banerjee, a ... the Nanoelectronics Research Lab at the University of California, ... international research award by the Electrostatic Discharge Association (ESDA). ... competitive and meant to recognize cutting edge research ideas ...
    Cached Biology Technology:Verenium to Present at Baird Clean Technology Conference 2Verenium to Present at Baird Clean Technology Conference 3Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies 2Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies 3UCSB professor receives award for graphene electronics research 2
    (Date:11/21/2014)... DALLAS , November 18, 2014 ... Security Systems Market by Systems (Video, RFID, Access Control, ... (SEZ, Factories, Hotels, Banks, Government), Component Service Geography - ... Security Systems Market is projected to be around $25 ... Billion by 2020, growing at a CAGR of 8.69%. ...
    (Date:11/21/2014)... , Nov. 20, 2014 C-Labs LLC, ... the Internet of Things (IoT), today announced the appointment ... chief operating officer. Previously a strategic advisor to the ... and operations. Mr. Traynor is based out of the ... He reports to Chris Muench , Chief Executive ...
    (Date:11/18/2014)... 17, 2014   News Highlights: ... to develop The Partners Data Lake, an agile ... Data Lake will allow researcher and clinicians to ... and the lives of patients , The ... activities across the Partners system, breaking down physical ...
    Breaking Biology News(10 mins):Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
    ... the University of Leicester are investigating how the stuff of ... the human reproductive system. Hydrogen sulphide partially responsible for ... gas and has been used for chemical warfare. But ... beneficial effects it has in the body- and the potentially ...
    ... way to turn off a key signaling pathway involved in ... and other diseases. The findings may lead to new treatments ... In the study, which is currently available in the online ... that by activating a receptor in cells called the liver ...
    ... billionths of a millimeter in size. Exhibiting novel and often ... stream of equally innovative products. In medical therapies, for example, ... into cells. So far, the only way of testing these ... show the activation of a transported gene inside a ...
    Cached Biology News:UCLA researchers discover new molecular pathway for targeting cancer, disease 2Chasing tiny vehicles 2Chasing tiny vehicles 3
    ... Contents include: Microarray hybridization chamber ... chamber top, clamp, thumbscrew) Microarray chamber user ... and are intended to be cleaned and ... with Agilents Catalog Oligo Microarray kits and ...
    Formula variant: With the macro- and micronutrients as described by Lloyd and McCown (1981). Preparation Quantity Equivalency: Formulated to contain 2.3 grams of powder per liter of medium. Physical ...
    ... Staining Kit is a very sensitive immunohistochemical ... cells, containing both anti-von Willebrand Factor and ... a variety of species. This AP kit ... staining of frozen and paraffin-embedded sections in ...
    ... For separation ... proteins Efficient separation of nuclei ... reduction in sample complexity, greatly ... proteins Subfractionation of nucleic acid ...
    Biology Products: